- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prevention of preterm birth
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1369KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 124KB)
Progesterone – November 2020
Progesterone: Pessary 200 mg; Oripro®
Last updated
5 March 2021